Hologic Inc. (HOLX)
-NasdaqGS | Prev Close: | 20.39 |
|---|
| Open: | N/A |
|---|
| Bid: | 19.90 x 100 |
|---|
| Ask: | 22.33 x 100 |
|---|
| 1y Target Est: | 24.39 |
|---|
| Beta: | 1.36 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 16.18 - 23.96 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 2,523,220 |
|---|
| Market Cap: | 5.49B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.39 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer DetectionPR Newswire(Thu, May 23)
- Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer ScreeningPR Newswire(Tue, May 21)
- HOLX July Options Begin Tradingat Forbes(Mon, May 20)
- JPMorgan: S&P at 1,715at Barrons.com(Fri, May 17)
- Analysis: Discount employee stock plans offer outsiders trading tipsReuters(Wed, May 15)
- HOLOGIC INC FinancialsEDGAR Online Financials(Wed, May 15)
- Short Interest Decreases By 12.7% For HOLXat Forbes(Fri, May 10)
- HOLX Crosses Above Key Moving Average Levelat TheStreet(Fri, May 10)
- 5 Stocks Driving The Health Services Industry Higherat TheStreet(Fri, May 10)
- 3 Industrials With Rapidly Increasing Debtat Seeking Alpha(Thu, May 9)
- Hologic to Present at Three Upcoming Investor ConferencesPR Newswire(Thu, May 9)
- HOLOGIC INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- Hologic Appoints Scott Garrett to Board of DirectorsPR Newswire(Wed, May 8)
- A Strategic Healthcare Deal With an Expensive Price Tagat Motley Fool(Wed, May 8)
- Recent Financials May Not Be Entirely Fair To Hologicat Investopedia(Wed, May 8)
Key Statistics
| Forward P/E (1 yr): | 11.65 |
|---|
| P/S (ttm): | 2.38 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 1.54 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.37 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | 1.14 |
|---|
Business Summary
Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for the healthcare needs of women. The companys Breast Health segment offers full field digital mammography systems, breast tomosy...
View More